December 14, 2015 / 2:11 PM / in 2 years

BUZZ-U.S. STOCKS ON THE MOVE-Apple, NephroGenex, GoPro, Newell

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were set to open little changed on Monday as investors brace for a widely expected rate hike and crude prices flirted with their 11-year lows. Dow Jones industrial average futures were up 0.07 percent at 17,273, S&P 500 futures were up 0.17 percent at 2,013.25 and Nasdaq 100 futures were up 0.06 percent at 4,541.75.

** TRINA SOLAR LTD, Friday close $9.55, +7.85 pct premarket

The Chinese solar panel maker said on Monday it received a preliminary proposal from its chief executive and Shanghai Xingsheng Equity Investment & Management Co to take the company private.

** ATARA BIOTHERAPEUTICS INC, Friday close $33.2, -36.14 pct premarket

The drug developer said it would stop developing its kidney drug after the treatment failed to meet the main goal of a mid-stage study.

** APPLE INC, Friday close $113.18, -1.30 pct premarket

Barclays and Morgan Stanley cut their price targets on the IPhone maker's stock. Morgan Stanley analysts in a note on Sunday said IPhone unit sales are expected to fall about 6 percent in FY16 as higher prices in markets outside the Americas, excluding China, and maturing smartphone penetration in developed markets weigh on upgrades and new user growth.

** GOPRO INC, Friday close $19.15, -5.22 pct premarket

Citigroup cut its rating on the wearable camera maker's stock to "neutral" from "buy" on Friday. It also slashed its price target to $22 from $75. Citigroup analysts said they had thought GoPro would recover from poor sales of Hero 4 Session but now think demand for GoPro products is softening.

Morgan Stanley also cut its rating to "underweight" from "equal-weight".

** NEPHROGENEX INC, Friday close $1.44, +27.78 pct premarket

The drug developer says the U.S. FDA allows human testing of its experimental drug to treat acute kidney injury. The drug is designed to reduce kidney injury, post-injury tissue scarring and improve kidney function recovery.

** JARDEN CORP, Friday close $52.68, +1.94 pct premarket

** NEWELL RUBBERMAID INC, Friday close $45.28, -7.82 pct premarket

Newell Rubbermaid, the maker of Sharpie markers and Parker pens, agreed to buy diversified consumer products company Jarden Corp for $13.22 billion, adding brands such as Sunbeam kitchen appliances and Coleman outdoor gear.

** TWITTER INC, Friday close $24.84, -0.64 pct premarket

The micro blogging site issued an alert to some users warning them that state-sponsored hackers may have tried to obtain sensitive data from their accounts, the company said, the first such warning by twitter.

** ALIBABA GROUP HOLDING LTD, Friday close $79.74, +0.80 pct premarket

The Chinese e-commerce company has agreed on a $266 million deal to acquire the South China Morning Post and other media assets of SCMP Group Ltd 0583.HK, a deal that has raised a question over the outlook for its editorial independence.

** KINDER MORGAN, Friday close $16.66, -1.44 pct premarket

The oil and gas pipeline operator shares do not appear cheap despite having fallen 60 percent this year, and could fall further before reaching fair value, U.S. weekly investment publication Barron's said in its Dec. 14 edition.

** ASTRAZENECA PLC, Friday close $33.25, -0.78 pct premarket

The drugmaker said on Monday it was in talks that might lead to the acquisition of privately held biotech firm Acerta Pharma, a potential $5 billion-plus deal designed to build up its cancer drug portfolio.

** VALEANT PHARMACEUTICALS INTERNATIONAL INC, Friday close $93.06, +0.96 pct premarket

The Canadian drugmaker under mounting pressure from Congress and prosecutors over its drug pricing, has hired an attorney in Washington, DC and crisis public relations experts with political connections, according to sources familiar with the matter.

** BAIDU INC, Friday close $193.68, -0.30 pct premarket

China's top online search firm said it aims to put self-driving buses on the road in three years and mass produce them within five years, after it set up a business unit to oversee all its efforts related to automobiles.

** DOW CHEMICAL CO, Friday close $53.37, -1.44 pct premarket

** DUPONT CO, Friday close $70.44, -1.26 pct premarket

Activist investor Daniel Loeb of hedge fund Third Point has called for the removal of Dow Chemical Chief Executive Officer Andrew Liveris after the company's agreement to merge with DuPont, the Wall Street Journal reported on Sunday.

** ENCANA CORP, Friday close $6.04, -4.80 pct premarket

The Canadian oil and natural gas producer, responding to a sharp drop in oil prices, has slashed its dividend by about 79 percent and its 2016 capital budget by more than a quarter.

** CHENIERE ENERGY INC, Friday close $41.29, +0.92 pct premarket

The company said on Sunday it would replace Chief Executive Charif Souki months after activist investor Carl Icahn took a big stake in the company as it prepared to become the first exporter of natural gas from the United States.

** HORIZON PHARMA, Friday close $18.99, +2.42 pct premarket

The specialty drug maker said on Friday it has agreed to buy Crealta Holdings for $510 million in cash, adding the only U.S.-approved treatment for a type of arthritis to its portfolio. (Reporting by Rosmi Shaji in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below